Holen Sie sich die Stockscreener-App
1.27
1.60%
0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTXR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.25
Offen:
$1.25
24-Stunden-Volumen:
175.31K
Relative Volume:
0.07
Marktkapitalisierung:
$13.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-39.14M
KGV:
-0.2127
EPS:
-5.97
Netto-Cashflow:
$-28.20M
1W Leistung:
-5.93%
1M Leistung:
-18.59%
6M Leistung:
-51.53%
1J Leistung:
-92.65%
1-Tages-Spanne:
$1.24
$1.34
1-Wochen-Bereich:
$1.20
$1.365
52-Wochen-Spanne:
$0.65
$17.00
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Firmenname
Citius Pharmaceuticals Inc
Sektor
Branche
Telefon
(908) 967-6676
Adresse
11 COMMERCE DRIVE, CRANFORD, NJ
Vergleichen Sie CTXR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.27 | 13.74M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.10 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
554.79 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
430.74 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
642.75 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
287.88 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Hochstufung | D. Boral Capital | Hold → Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
Citius Pharmaceuticals Inc Aktie (CTXR) Neueste Nachrichten
Chart overlay techniques for tracking Citius Pharmaceuticals Inc.Swing Trade Entry and Exit Point Analysis - Newser
Tools to assess Citius Pharmaceuticals Inc.’s risk profileVolume Spike Detection for Early Breakouts - Newser
Sector ETF performance correlation with Citius Pharmaceuticals Inc.Risk Shielded Trade Watch with Analysis - Newser
Is Citius Pharmaceuticals Inc. stock a growth or value playWeekly Breakout Forecast with Entry Zones - Newser
Citius Pharmaceuticals (CTXR) Expected to Announce Quarterly Earnings on Monday - Defense World
Citius CTXR 2025Q3 Earnings Preview Upside Ahead on Potential New Product Launch - AInvest
Why Citius Pharmaceuticals Inc. is moving todaySummary of Reliable Long-Term Trade Models - Newser
Published on: 2025-08-04 16:39:39 - beatles.ru
Published on: 2025-08-04 09:23:45 - beatles.ru
What is the dividend policy of Citius Pharmaceuticals Inc. stockMaximize your gains with expert trading tips - Jammu Links News
When is Citius Pharmaceuticals Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News
What are Citius Pharmaceuticals Inc. company’s key revenue driversUnstoppable trading performance - Jammu Links News
What institutional investors are buying Citius Pharmaceuticals Inc. stockAchieve breakthrough investment performance - Jammu Links News
Is Citius Pharmaceuticals Inc. a good long term investmentExceptional ROI - Jammu Links News
Why is Citius Pharmaceuticals Inc. stock attracting strong analyst attentionExceptional trading performance - Jammu Links News
What makes Citius Pharmaceuticals Inc. stock price move sharplyTrack stocks with high upside potential easily - Jammu Links News
How many analysts rate Citius Pharmaceuticals Inc. as a “Buy”Accelerated investment success - Jammu Links News
How does Citius Pharmaceuticals Inc. compare to its industry peersFree Stock Watchlist For Fast Growth - Jammu Links News
What are the technical indicators suggesting about Citius Pharmaceuticals Inc.Chart Pattern Trend Scanner With Low Risk - Jammu Links News
What is Citius Pharmaceuticals Inc. company’s growth strategyRetirement Planning Review With Proven Results - Jammu Links News
Is Citius Pharmaceuticals Inc. reversing from oversold territoryIntraday Trend Analysis for Fast Gains Released - metal.it
Citius Pharmaceuticals Inc. Chart Enters High Volatility ZoneCommunity Entry Consensus Trade Ideas Shared - metal.it
Wyckoff Accumulation Phase Possible in Citius Pharmaceuticals Inc.Weekly Chart Analysis With Entry Advice Provided - metal.it
Is Citius Pharmaceuticals Inc. stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News
Is it the right time to buy Citius Pharmaceuticals Inc. stockBuild wealth steadily with expert advice - Jammu Links News
What is the risk reward ratio of investing in Citius Pharmaceuticals Inc. stockBreakout profit opportunities - Jammu Links News
What are analysts’ price targets for Citius Pharmaceuticals Inc. in the next 12 monthsDiscover breakthrough stocks with expert help - Jammu Links News
How Citius Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Signals - metal.it
What analysts say about Citius Pharmaceuticals Inc. stockFree Investment Community - printweek.in
Citius Pharmaceuticals Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider
What drives Citius Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - jammulinksnews.com
Finanzdaten der Citius Pharmaceuticals Inc-Aktie (CTXR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
2.85%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):